Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…
HOME > BUSINESS
BUSINESS
- Harvoni Tops Japan Yearly Sales Ranking Only 7 Months after Launch: IMS
May 18, 2016
- ASKA Dissolves Generic JV with Actavis
May 17, 2016
- Medipal to Set Up Subsidiary for Specialty Drugs
May 17, 2016
- Lilly, Kanazawa Medical Univ. Ink Research Deal on Diffuse-Type Gastric Cancer
May 17, 2016
- Top 8 Japan Drug Makers Relish 2.6-Fold Operating Profit Jump on Global Brands
May 17, 2016
- Chugai’s CellCept, Generic Versions Approved for Lupus Nephritis
May 17, 2016
- Nippon Kayaku Faces Damage Suit over Elplat Patent
May 17, 2016
- Santen Anticipates Continued Growth in Sales of Ikervis in Europe; 30% Overseas Sales Ratio an “Achievable Target”
May 17, 2016
- As Tagrisso Launch Nears, AZ Pushes Stringent Prerequisites for Facilities, Doctors to Ensure Safety
May 17, 2016
- Towa to Mull Over Distribution Dealing with Wholesalers
May 17, 2016
- Eisai Aims for 10% Rise in Japan Pharma Sales with Patented Products: CEO
May 16, 2016
- Eisai Posts Higher Profits despite Sales Dip, Global Brands Expand
May 16, 2016
- Kyorin Enthusiastic about Overcoming “Kipres Cliff,” Aiming for Over 50% Share with AG, 4 New Product Launches
May 16, 2016
- Ono to Erect New Opdivo Plant, Operational Launch Eyed for 2020
May 13, 2016
- US Merck Links Up with Univ. of Tokyo on Drug Discovery
May 13, 2016
- Takeda Taps Ex-Kraft Foods CFO Kehoe as New CFO
May 13, 2016
- Daiichi Sankyo CEO Sees High Odds of Success for AML Drug Quizartinib
May 13, 2016
- Daiichi Sankyo Sees 7.3% Sales Rise, but Girding for FY2016 Dip on Olmesartan Cliff
May 13, 2016
- Kissei Ditches Constipation Drug KWA-0711, Turns to Other Products for GI Entry
May 13, 2016
- Nichi-Iko to Develop 3 Biosimilars for Global Market, Aims to Enter as Global Top-10 Generic Maker within 3 Years
May 13, 2016
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…